SNCA and Parkinson disease: Thus, El-Agnaf et al. developed a novel ELISA that detects exclusively oligomeric “soluble aggregates” of α-synuclein [23], and found that oligomeric forms of α-synuclein were significantly elevated in serum samples from PD patients compared with non-PD controls.